{tiny;ARIA;3}ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) will hold a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Thursday, November 5, 2009. Harvey J. Berger, M.D., chairman and chief executive officer, will host the call. Senior management will discuss the Company’s financial results for the nine months ended September 30, 2009, progress toward 2009 key corporate objectives and additional corporate activities.
The live webcast can be accessed by visiting the investor relations section of the Company’s website at http://www.ariad.com/investor. The call can be accessed by dialing 866-783-2146 (domestic) or 857-350-1605 (international) five minutes prior to the start time and providing the passcode 97543712. A replay of the call will be available on the ARIAD website approximately two hours after completion of the call and will be archived for two weeks.
{tiny;OSIR;3}Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the quarter ended September 30, 2009, on Wednesday, November 4, 2009. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Wednesday, November 4, 2009 at 9:00 a.m. ET.
To access the webcast, visit the Investor Relations section of the company's website at http://investor.osiris.com/events.cfm. Alternatively, callers may participate in the conference call by dialing (866) 431-2027 (U.S. participants) or (719) 325-2274 (international participants).
A replay of the conference call will be available approximately two hours after the completion of the call through November 18, 2009. Callers can access the replay by dialing (888) 203-1112 (U.S. participants) or (719) 457-0820 (international participants). The audio replay passcode is 6412442. To access a replay of the webcast, visit the Investor Relations section of the company's website at http://investor.osiris.com/events.cfm.
{tiny;insm;3}Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today announced that it will host a conference call on Friday, November 6th, at 8:30 AM ET, to discuss its financial results for the third quarter 2009. Insmed intends to issue its quarterly financial results press release before the market opens on November 6th.
To participate in the live conference call, please dial 800-573-4754 (U.S. callers) or 617-224-4325 (international), and provide passcode 14720373. A live webcast of the call will also be available at http://phx.corporate-ir.net/playerlink.zhtml?c=122332&s=wm&e=2498647. Please allow extra time prior to the webcast to register, download and install any necessary audio software.
The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 11:30 AM ET on November 6th at 888-286-8010 (U.S. callers) or 617-801-6888 (international), using passcode 92577797.
{tiny;CRIS;3}Curis, Inc. (NASDAQ:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will release its third quarter financial results on Thursday, October 29, 2009 before the market opens. The Company will also hold a conference call on the same day at 9:00 A.M. Eastern time to discuss: (i) its Hedgehog Pathway Inhibitor program under collaboration with Genentech, (ii) its August 2009 license agreement with Debiopharm under which the Company’s Hsp90 inhibitor technologies, including Debio 0932 (formerly CUDC-305), were exclusively licensed, (iii) CUDC-101 and other proprietary targeted cancer programs, (iv) its financial results as of and for the three- and nine-month periods ended September 30, 2009, and (v) additional corporate activities. Daniel Passeri, President and Chief Executive Officer of Curis, will host the call.To access the live conference call, please call (800) 569-2037 from the United States or Canada or (617) 614-2713 from other locations, shortly before 9:00 A.M. EDT. The conference ID number is 77811969. The conference call can also be accessed on the Curis website at www.curis.com in the Investors section. Replay will be available approximately two hours after the completion of the call and through 5:00 P.M. EST, Thursday, November 5, 2009. To access the replay, please call (888) 286-8010 from the United States or Canada or (617) 801-6888 from other locations and reference the conference ID number 60149533.
{tiny;IMGN;3}ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company’s financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen’s 2010 fiscal year. Management also will provide an update on the Company.
To access the live call by phone, dial 913-312-6698. Passcode is 6451192. The call also may be accessed through the Investor Information section of the Company’s website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 5, 2009.
{tiny;QCOR;3}Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the third quarter ended September 30, 2009 on Monday, November 2, 2009 after the market close. The Company will host a conference call and webcast on Monday, November 2, 2009 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the Company's second quarter and current corporate developments. The dial-in number for the conference call is 480-629-9723 for domestic participants and 877-941-2332 for international participants.
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4169702#. To access the live webcast of the call, go to Questcor Pharmaceuticals' website at www.questcor.com. An archived webcast will also be available at www.questcor.com.
{tiny;NSPH;3}Nanosphere, Inc., (Nasdaq:NSPH), which develops, manufactures, and markets advanced molecular diagnostics systems, will report its results for the third quarter of 2009 after market close on Thursday, November 5, 2009. The company will also hold a live investor conference call and webcast at 5:00 P.M., Eastern Time.
The teleconference can be accessed by dialing 888.713.4218 (U.S./Canada) or 617.213.4870 (international), participant code 68742213. The call will also be broadcast live over the Internet and can be accessed by interested parties at the Investor Relations tab on the Nanosphere website: www.nanosphere.us.
Participants may pre-register for the call at: https://www.theconferencingservice.com/prereg/key.process?key=PCA9ULWQT Pre-registrants will be issued a pin number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection. For interested individuals unable to join the call or webcast, a replay will be available through November 11, 2009 by dialing 888-286-8010 or for international calls 617-801-6888, pass code 80886974, or on the company's website.
{tiny;PDLI;3}PDL BioPharma, Inc. (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on Wednesday, October 28 at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter of 2009 and provide a business update. The call and webcast will follow the release of the third quarter ended September 30, 2009 financial results after market close.
To access the live conference call via phone, please dial (866) 804-6928 from the United States and Canada or (857) 350-1674 internationally. The conference ID is 28992227. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 3, 2009 and may be accessed by dialing (888) 286-8010 from the United States and Canada or (617) 801-6888 internationally. The replay passcode is 78436903.
{tiny;IDIX;3}Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the third quarter of 2009 on Thursday, October 29, 2009 after U.S. financial markets close.
In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Thursday, October 29, 2009 to discuss the company's financial results for the third quarter of 2009 and provide an update on the company's discovery and development programs.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 37050246 or to listen to a live webcast and view accompanying slides, go to "Calendar of Events" in the Idenix Investor Center at www.idenix.com. A replay of the call will also be available from October 29, 2009, 6:30 p.m. ET until November 11, 2009, 11:59 p.m. ET. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 37050246. An archived webcast will also be available for two weeks after the call on the Idenix website.
{tiny;ANDS;3}Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report third quarter 2009 financial results on Thursday, October 29, 2009, after the U.S. financial markets close.
Anadys will hold a conference call and webcast on Thursday, October 29, 2009 at 5:00 p.m. Eastern Daylight Time to discuss its third quarter 2009 financial results and highlights and to provide an update on the ANA598 program. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 81828355. The webcast and telephone replay will be available through November 12, 2009.
Thursday, August 13 may mark the height of earnings season as the Dow Jones Industrial Average (.DJI) and S&P 500 index (.INX) will find themselves subject to the news that comes out of many sectors, but especially retail.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
Retail giant Wal-Mart Stores Inc. (WMT), a Dow component, is set to publish second-quarter score card at 07:00 am ET on Thursday, but that isn't the only player on the docket later this week.
Design software maker Autodesk Inc. (ADSK) will layout second-quarter results Thursday, with analysts projecting earnings of $0.19 per share on revenues of $413.17 million. In mid-May, the company said it expects second-quarter GAAP loss to range between $0.03 and $0.09 per share and non-GAAP earnings in the range of $0.15 - $0.20 per share, with revenue of $395 million - $420 million.
Educational services provider DeVry (DV) is set to give out fourth-quarter progress card on Thursday, as analysts are expecting earnings of $0.51 per share on revenues of $376.92 million.
Non-alcoholic beverages maker Dr Pepper Snapple Group Inc. (DPS) will furnish second-quarter numbers before the market opens Thursday, with analysts forecasting earnings of $0.49 per share on revenues of $1.50 billion. While releasing first-quarter results, the company said it currently expects fiscal 2009 earnings to range between $1.85 and $1.93 per share, up from the prior guidance range of $1.71 - $1.79 per share. Dr Pepper Snapple also raised its adjusted earnings forecast to a range of $1.70 - $1.78 per share from its prior estimate of $1.59 - $1.67 per share. Analysts expect the company to report earnings of $1.77 per share for fiscal 2009.
Further, Dr Pepper Snapple continues to anticipate full-year net sales to be down 2% to 4%. Excluding the loss of Hansen product distribution and currency fluctuations, the company expects net sales to grow 2% to 4%.
Department store operator Kohls Corp. (KSS) will annunciate second-quarter figures Thursday, with analysts projecting earnings of $0.73 per share on revenues of $3.78 billion. The company, in mid-May, said it projects second-quarter earnings between $0.56 and $0.64 per share. For fiscal 2009, Kohl's updated its earnings per share outlook range to $2.19 - $2.42 from prior range of $2.00 - $2.30 per share. Analysts are looking for earnings of $2.66 per share for the full year.
Fashion specialty retailer Nordstrom (JWN) will publicize second-quarter score card after the market closes Thursday, as analysts are expecting earnings of $0.45 per share on revenues of $2.13 billion. On May 14, Nordstrom raised its fiscal 2009 earnings outlook to a range of $1.25 - $1.50 from its previous estimate of $1.10 - $1.40 per share. Analysts are looking for earnings of $1.38 per share for the full year.
Personal care products maker Estée Lauder Companies Inc. (EL) is set to report fourth-quarter results Thursday before the market opens, with analysts forecasting earnings of $0.20 per share on revenues of $1.72 billion.
While releasing third-quarter numbers, Estée Lauder said it currently expects fiscal 2009 earnings, before restructuring and other special charges, to range between $1.32 and $1.44 per share, including the expected negative impact of foreign currency translation of about $0.21 - $0.23 per share. Net sales are expected to drop 1% - 3% in constant currency. Previously, Estée Lauder projected earnings in the range of $1.30 - $1.60 per share, including the anticipated negative impact of foreign currency translation of about $0.25 - $0.27 per share., while sales were expected to be flat to down 3% in constant currency.
For the lifestyle specialty retailer Urban Outfitters Inc. (URBN), analysts are looking for earnings of $0.26 per share on revenues of $457.15 million for the second quarter. The results are due to be released on Thursday. On August 6, the company reported 1% rise in second-quarter net sales that totaled $458.6 million, compared to $454.3 million reported a year ago.
Other prime players to tag along with the retail giants in releasing quarterly results on Thursday include AmBev - Companhia de Bebidas Das Americas (ABV), Blockbuster Inc. (BBI), Gildan Activewear (GIL), Insmed Inc. (INSM), URS Corp. (URS).
Retail giant Wal-Mart Stores Inc. (WMT), a Dow component, is set to publish second-quarter score card at 07:00 am ET on Thursday, but that isn't the only player on the docket later this week.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
Design software maker Autodesk Inc. (ADSK) will layout second-quarter results Thursday, with analysts projecting earnings of $0.19 per share on revenues of $413.17 million. In mid-May, the company said it expects second-quarter GAAP loss to range between $0.03 and $0.09 per share and non-GAAP earnings in the range of $0.15 - $0.20 per share, with revenue of $395 million - $420 million.
Educational services provider DeVry (DV) is set to give out fourth-quarter progress card on Thursday, as analysts are expecting earnings of $0.51 per share on revenues of $376.92 million.
Non-alcoholic beverages maker Dr Pepper Snapple Group Inc. (DPS) will furnish second-quarter numbers before the market opens Thursday, with analysts forecasting earnings of $0.49 per share on revenues of $1.50 billion. While releasing first-quarter results, the company said it currently expects fiscal 2009 earnings to range between $1.85 and $1.93 per share, up from the prior guidance range of $1.71 - $1.79 per share. Dr Pepper Snapple also raised its adjusted earnings forecast to a range of $1.70 - $1.78 per share from its prior estimate of $1.59 - $1.67 per share. Analysts expect the company to report earnings of $1.77 per share for fiscal 2009.
Further, Dr Pepper Snapple continues to anticipate full-year net sales to be down 2% to 4%. Excluding the loss of Hansen product distribution and currency fluctuations, the company expects net sales to grow 2% to 4%.
Department store operator Kohls Corp. (KSS) will annunciate second-quarter figures Thursday, with analysts projecting earnings of $0.73 per share on revenues of $3.78 billion. The company, in mid-May, said it projects second-quarter earnings between $0.56 and $0.64 per share. For fiscal 2009, Kohl's updated its earnings per share outlook range to $2.19 - $2.42 from prior range of $2.00 - $2.30 per share. Analysts are looking for earnings of $2.66 per share for the full year.
Fashion specialty retailer Nordstrom (JWN) will publicize second-quarter score card after the market closes Thursday, as analysts are expecting earnings of $0.45 per share on revenues of $2.13 billion. On May 14, Nordstrom raised its fiscal 2009 earnings outlook to a range of $1.25 - $1.50 from its previous estimate of $1.10 - $1.40 per share. Analysts are looking for earnings of $1.38 per share for the full year.
Personal care products maker Estée Lauder Companies Inc. (EL) is set to report fourth-quarter results Thursday before the market opens, with analysts forecasting earnings of $0.20 per share on revenues of $1.72 billion.
While releasing third-quarter numbers, Estée Lauder said it currently expects fiscal 2009 earnings, before restructuring and other special charges, to range between $1.32 and $1.44 per share, including the expected negative impact of foreign currency translation of about $0.21 - $0.23 per share. Net sales are expected to drop 1% - 3% in constant currency. Previously, Estée Lauder projected earnings in the range of $1.30 - $1.60 per share, including the anticipated negative impact of foreign currency translation of about $0.25 - $0.27 per share., while sales were expected to be flat to down 3% in constant currency.
For the lifestyle specialty retailer Urban Outfitters Inc. (URBN), analysts are looking for earnings of $0.26 per share on revenues of $457.15 million for the second quarter. The results are due to be released on Thursday. On August 6, the company reported 1% rise in second-quarter net sales that totaled $458.6 million, compared to $454.3 million reported a year ago.
Other prime players to tag along with the retail giants in releasing quarterly results on Thursday include AmBev - Companhia de Bebidas Das Americas (ABV), Blockbuster Inc. (BBI), Gildan Activewear (GIL), Insmed Inc. (INSM), URS Corp. (URS).
August 14
Teen apparel retailer Abercrombie & Fitch Co. (ANF) will publicize second-quarter numbers before the market opens Friday, with analysts expecting a loss of $0.06 per share. Net sales for the quarter dropped 23% to $648.5 million, topping analysts' consensus revenue estimate of $648.05 million.
Department store chain J.C. Penney Co. Inc. (JCP) will issue dollars-and-cents trivia for the second quarter, as analysts are expecting a loss of $0.03 per share on revenues of $3.95 billion for the quarter. Most recently, the company said it currently projects a second-quarter loss of about $0.01 per share, versus the prior outlook range of loss $0.08 - $0.12 per share. The company noted that the outlook revision was based on better than expected sales in July and continued improvement in gross margin and operating expenses.
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response lette (...)[More...]
Below is a sample of entries from the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The companies outlined below have expected FDA new drug product decisions or clinical trial results expected over the next three months of summer. The list also includes some Extreme Trades of companies with market caps below $250 million that have pending clinical trial results or FDA decisions that could have a major stock price impact. Rigel Pharma (NASDAQ:RIGL): On 5/5/09, (...)[More...]
All News |
Breaking News |
Featured Stories